{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T19:26:24Z","timestamp":1774466784711,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T00:00:00Z","timestamp":1747526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T00:00:00Z","timestamp":1747526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Uppsala University Hospital research fund"},{"name":"Regional Research council Mid Sweden","award":["RFR-560491"],"award-info":[{"award-number":["RFR-560491"]}]},{"name":"Regional Research council Mid Sweden","award":["RFR-560491"],"award-info":[{"award-number":["RFR-560491"]}]},{"DOI":"10.13039\/501100001858","name":"VINNOVA","doi-asserted-by":"publisher","award":["2018-03340"],"award-info":[{"award-number":["2018-03340"]}],"id":[{"id":"10.13039\/501100001858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001858","name":"VINNOVA","doi-asserted-by":"publisher","award":["2018-03340"],"award-info":[{"award-number":["2018-03340"]}],"id":[{"id":"10.13039\/501100001858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Estimated glomerular filtration rate (eGFR) based on creatinine (eGFR<jats:sub>Creatinine<\/jats:sub>) or cystatin C (eGFR<jats:sub>CystatinC<\/jats:sub>) require steady-state conditions and thus have limitations in intensive care unit (ICU) patients. Gentamicin is a potential exogenous marker for eGFR but poorly investigated. This retrospective study included adult ICU patients (<jats:italic>\u2265<\/jats:italic>\u200918 years) treated with gentamicin and not on renal replacement therapy (RRT) at admission. eGFR<jats:sub>Creatinine<\/jats:sub> and eGFR<jats:sub>CystatinC<\/jats:sub> were calculated using the LM-rev and CAPA equations, respectively. Gentamicin clearance was estimated using a population pharmacokinetic model and used as eGFR<jats:sub>Gentamicin<\/jats:sub>. Agreement between eGFRs vs. eGFR<jats:sub>Gentamicin<\/jats:sub> and prediction of RRT and mortality for each eGFR were assessed. 254 patients were included of whom 11% (<jats:italic>n<\/jats:italic>\u2009=\u200928) received RRT later and 19% (<jats:italic>n<\/jats:italic>\u2009=\u200949) were dead at 30 days. The bias was 12 mL\/min\/1.73 m<jats:sup>2<\/jats:sup> and 8 mL\/min\/1.73 m<jats:sup>2<\/jats:sup>, respectively, and the limits of agreement \u2212\u200931\u201355 mL\/min\/1.73m<jats:sup>2<\/jats:sup> and \u2212\u200946\u201362 mL\/min\/1.73m<jats:sup>2<\/jats:sup> for the agreement between eGFR<jats:sub>Gentamicin<\/jats:sub> vs. eGFR<jats:sub>Creatinine<\/jats:sub>, and for eGFR<jats:sub>Gentamicin<\/jats:sub> vs. eGFR<jats:sub>CystatinC<\/jats:sub>, respectively. The c-indexes for predicting RRT during ICU stay were 0.75 (0.64\u20130.86), 0.77 (0.66\u20130.88) and 0.80 (0.69\u20130.90) for eGFR<jats:sub>Creatinine<\/jats:sub>, eGFR<jats:sub>CystatinC<\/jats:sub> and eGFR<jats:sub>Gentamicin<\/jats:sub> respectively, and for 30-day mortality 0.61 (0.52\u20130.70), 0.61 (0.52\u20130.70) and 0.63 (0.54\u20130.72) respectively. In ICU patients already receiving gentamicin, eGFR<jats:sub>Gentamicin<\/jats:sub> derived from population PK models can be used to assess renal function and could potentially help improve dosing of other renally cleared drugs like the \u03b2-lactams during early phase of infections in the ICU.<\/jats:p>","DOI":"10.1038\/s41598-025-01256-z","type":"journal-article","created":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T18:28:43Z","timestamp":1747592923000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Utilizing gentamicin concentrations to estimate glomerular filtration rate in intensive care unit patients"],"prefix":"10.1038","volume":"15","author":[{"given":"Anna-Karin","family":"Smekal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Swartling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabet I.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mia","family":"Furebring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders O.","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miklos","family":"Lipcsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,18]]},"reference":[{"issue":"4","key":"1256_CR1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ijantimicag.2014.12.017","volume":"45","author":"A Huttner","year":"2015","unstructured":"Huttner, A. et al. Augmented renal clearance, low \u03b2-lactam concentrations and clinical outcomes in the critically ill: an observational prospective cohort study. Int. J. Antimicrob. Agents. 45 (4), 385\u2013392 (2015).","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"1","key":"1256_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.accpm.2017.06.006","volume":"37","author":"C Carrie","year":"2018","unstructured":"Carrie, C. et al. Association between augmented renal clearance and clinical failure of antibiotic treatment in brain-injured patients with ventilator-acquired pneumonia: A preliminary study. Anaesth. Crit. Care Pain Med. 37 (1), 35\u201341 (2018).","journal-title":"Anaesth. Crit. Care Pain Med."},{"key":"1256_CR3","doi-asserted-by":"crossref","unstructured":"Mahmoud, S. H. & Shen, C. Augmented renal clearance in critical illness: an important consideration in drug dosing. Pharmaceutics, 9(3). (2017).","DOI":"10.3390\/pharmaceutics9030036"},{"issue":"5","key":"1256_CR4","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s13318-022-00779-4","volume":"47","author":"F Hefny","year":"2022","unstructured":"Hefny, F. et al. Drug dosing in critically ill adult patients with augmented renal clearance. Eur. J. Drug Metab. Pharmacokinet. 47 (5), 607\u2013620 (2022).","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"issue":"5","key":"1256_CR5","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s00134-008-1367-2","volume":"35","author":"SM Bagshaw","year":"2009","unstructured":"Bagshaw, S. M. et al. Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy. Intensive Care Med. 35 (5), 871\u2013881 (2009).","journal-title":"Intensive Care Med."},{"issue":"8","key":"1256_CR6","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.2215\/CJN.04360514","volume":"10","author":"J Bouchard","year":"2015","unstructured":"Bouchard, J. et al. A prospective international multicenter study of AKI in the intensive care unit. Clin. J. Am. Soc. Nephrol. 10 (8), 1324\u20131331 (2015).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"1","key":"1256_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/ndt\/gfad142","volume":"39","author":"A Zarbock","year":"2023","unstructured":"Zarbock, A. et al. Sepsis-associated acute kidney injury-treatment standard. Nephrol. Dial Transpl. 39 (1), 26\u201335 (2023).","journal-title":"Nephrol. Dial Transpl."},{"issue":"3","key":"1256_CR8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1053\/j.ajkd.2014.04.010","volume":"64","author":"I Soveri","year":"2014","unstructured":"Soveri, I. et al. Measuring GFR: a systematic review. Am. J. Kidney Dis. 64 (3), 411\u2013424 (2014).","journal-title":"Am. J. Kidney Dis."},{"issue":"1","key":"1256_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/2052-0492-2-31","volume":"2","author":"S Sunder","year":"2014","unstructured":"Sunder, S. et al. Estimation of renal function in the intensive care unit: the Covert concepts brought to light. J. Intensive Care. 2 (1), 31 (2014).","journal-title":"J. Intensive Care"},{"issue":"12","key":"1256_CR10","doi-asserted-by":"publisher","first-page":"100727","DOI":"10.1016\/j.xkme.2023.100727","volume":"5","author":"OM Adingwupu","year":"2023","unstructured":"Adingwupu, O. M. et al. Cystatin C as a GFR Estimation marker in acute and chronic illness: A systematic review. Kidney Med. 5 (12), 100727 (2023).","journal-title":"Kidney Med."},{"key":"1256_CR11","doi-asserted-by":"publisher","first-page":"110608","DOI":"10.1016\/j.clinbiochem.2023.110608","volume":"118","author":"R Roy","year":"2023","unstructured":"Roy, R. et al. The Estimation of glomerular filtration in acute and critical illness: challenges and opportunities. Clin. Biochem. 118, 110608 (2023).","journal-title":"Clin. Biochem."},{"issue":"2","key":"1256_CR12","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jfma.2013.10.002","volume":"113","author":"C Chen","year":"2014","unstructured":"Chen, C. et al. Update on new medicinal applications of gentamicin: evidence-based review. J. Formos. Med. Assoc. 113 (2), 72\u201382 (2014).","journal-title":"J. Formos. Med. Assoc."},{"issue":"6","key":"1256_CR13","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1177\/0310057X0903700611","volume":"37","author":"TE Jones","year":"2009","unstructured":"Jones, T. E., Peter, J. V. & Field, J. Aminoglycoside clearance is a good estimate of creatinine clearance in intensive care unit patients. Anaesth. Intensive Care. 37 (6), 944\u2013952 (2009).","journal-title":"Anaesth. Intensive Care"},{"issue":"8","key":"1256_CR14","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1097\/00003246-199108000-00012","volume":"19","author":"KG Hickling","year":"1991","unstructured":"Hickling, K. G. et al. Serum aminoglycoside clearance is predicted as poorly by renal aminoglycoside clearance as by creatinine clearance in critically ill patients. Crit. Care Med. 19 (8), 1041\u20131047 (1991).","journal-title":"Crit. Care Med."},{"issue":"10","key":"1256_CR15","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1177\/106002809202601001","volume":"26","author":"BJ Zarowitz","year":"1992","unstructured":"Zarowitz, B. J., Robert, S. & Peterson, E. L. Prediction of glomerular filtration rate using aminoglycoside clearance in critically ill medical patients. Ann. Pharmacother. 26 (10), 1205\u20131210 (1992).","journal-title":"Ann. Pharmacother"},{"issue":"1","key":"1256_CR16","doi-asserted-by":"publisher","first-page":"5882","DOI":"10.1038\/s41598-021-85370-8","volume":"11","author":"J Helmersson-Karlqvist","year":"2021","unstructured":"Helmersson-Karlqvist, J. et al. Cystatin C predicts long term mortality better than creatinine in a nationwide study of intensive care patients. Sci. Rep. 11 (1), 5882 (2021).","journal-title":"Sci. Rep."},{"issue":"5","key":"1256_CR17","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1053\/j.ajkd.2021.04.016","volume":"78","author":"LA Inker","year":"2021","unstructured":"Inker, L. A. & Titan, S. Measurement and Estimation of GFR for use in clinical practice: core curriculum 2021. Am. J. Kidney Dis. 78 (5), 736\u2013749 (2021).","journal-title":"Am. J. Kidney Dis."},{"issue":"1","key":"1256_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41581-019-0191-y","volume":"16","author":"AS Levey","year":"2020","unstructured":"Levey, A. S. et al. Measured and estimated glomerular filtration rate: current status and future directions. Nat. Rev. Nephrol. 16 (1), 51\u201364 (2020).","journal-title":"Nat. Rev. Nephrol."},{"issue":"10","key":"1256_CR19","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1093\/clinchem\/38.10.1933","volume":"38","author":"RD Perrone","year":"1992","unstructured":"Perrone, R. D., Madias, N. E. & Levey, A. S. Serum creatinine as an index of renal function: new insights into old concepts. Clin. Chem. 38 (10), 1933\u20131953 (1992).","journal-title":"Clin. Chem."},{"key":"1256_CR20","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1146\/annurev.me.39.020188.002341","volume":"39","author":"AS Levey","year":"1988","unstructured":"Levey, A. S., Perrone, R. D. & Madias, N. E. Serum creatinine and renal function. Annu. Rev. Med. 39, 465\u2013490 (1988).","journal-title":"Annu. Rev. Med."},{"key":"1256_CR21","doi-asserted-by":"publisher","first-page":"106342","DOI":"10.1016\/j.ejps.2022.106342","volume":"180","author":"Y Ma","year":"2023","unstructured":"Ma, Y. et al. Characterization of the renal tubular transport of creatinine by activity-based protein profiling and transport kinetics. Eur. J. Pharm. Sci. 180, 106342 (2023).","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"1256_CR22","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12882-020-01736-6","volume":"21","author":"X Zhang","year":"2020","unstructured":"Zhang, X. et al. Tubular secretion of creatinine and kidney function: an observational study. BMC Nephrol. 21 (1), 108 (2020).","journal-title":"BMC Nephrol."},{"issue":"1","key":"1256_CR23","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1053\/j.ajkd.2012.12.022","volume":"62","author":"GM McMahon","year":"2013","unstructured":"McMahon, G. M. & Waikar, S. S. Biomarkers in nephrology: core curriculum 2013. Am. J. Kidney Dis. 62 (1), 165\u2013178 (2013).","journal-title":"Am. J. Kidney Dis."},{"issue":"3","key":"1256_CR24","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1053\/j.ajkd.2017.03.021","volume":"70","author":"MC Foster","year":"2017","unstructured":"Foster, M. C. et al. Non-GFR determinants of Low-Molecular-Weight serum protein filtration markers in the elderly: AGES-Kidney and MESA-Kidney. Am. J. Kidney Dis. 70 (3), 406\u2013414 (2017).","journal-title":"Am. J. Kidney Dis."},{"issue":"6","key":"1256_CR25","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/ki.2008.638","volume":"75","author":"LA Stevens","year":"2009","unstructured":"Stevens, L. A. et al. Factors other than glomerular filtration rate affect serum Cystatin C levels. Kidney Int. 75 (6), 652\u2013660 (2009).","journal-title":"Kidney Int."},{"issue":"1","key":"1256_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clinbiochem.2004.09.025","volume":"38","author":"G Filler","year":"2005","unstructured":"Filler, G. et al. Cystatin C as a marker of GFR\u2013history, indications, and future research. Clin. Biochem. 38 (1), 1\u20138 (2005).","journal-title":"Clin. Biochem."},{"issue":"6","key":"1256_CR27","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/clpt.1985.245","volume":"38","author":"G Koren","year":"1985","unstructured":"Koren, G., James, A. & Perlman, M. A simple method for the Estimation of glomerular filtration rate by gentamicin pharmacokinetics during routine drug monitoring in the newborn. Clin. Pharmacol. Ther. 38 (6), 680\u2013685 (1985).","journal-title":"Clin. Pharmacol. Ther."},{"issue":"15","key":"1256_CR28","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1001\/jama.2011.468","volume":"305","author":"CA Peralta","year":"2011","unstructured":"Peralta, C. A. et al. Detection of chronic kidney disease with creatinine, Cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. Jama 305 (15), 1545\u20131552 (2011).","journal-title":"Jama"},{"issue":"1","key":"1256_CR29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13613-022-01066-w","volume":"12","author":"A Sitbon","year":"2022","unstructured":"Sitbon, A. et al. Accuracy of clinicians\u2019 ability to predict the need for renal replacement therapy: a prospective multicenter study. Ann. Intensive Care. 12 (1), 95 (2022).","journal-title":"Ann. Intensive Care"},{"issue":"4","key":"1256_CR30","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1136\/heartjnl-2020-318860","volume":"108","author":"J Helmersson-Karlqvist","year":"2022","unstructured":"Helmersson-Karlqvist, J. et al. Addition of Cystatin C predicts cardiovascular death better than creatinine in intensive care. Heart 108 (4), 279\u2013284 (2022).","journal-title":"Heart"},{"issue":"10","key":"1256_CR31","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/NEJMoa1214234","volume":"369","author":"MG Shlipak","year":"2013","unstructured":"Shlipak, M. G. et al. Cystatin C versus creatinine in determining risk based on kidney function. N Engl. J. Med. 369 (10), 932\u2013943 (2013).","journal-title":"N Engl. J. Med."},{"issue":"12","key":"1256_CR32","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1161\/STROKEAHA.107.489625","volume":"38","author":"L Ni","year":"2007","unstructured":"Ni, L. et al. Cystatin C, associated with hemorrhagic and ischemic stroke, is a strong predictor of the risk of cardiovascular events and death in Chinese. Stroke 38 (12), 3287\u20133288 (2007).","journal-title":"Stroke"},{"key":"1256_CR33","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3389\/fphar.2020.00620","volume":"11","author":"W Kantasiripitak","year":"2020","unstructured":"Kantasiripitak, W. et al. Software tools for Model-Informed precision dosing: how well do they satisfy the needs?? Front. Pharmacol. 11, 620 (2020).","journal-title":"Front. Pharmacol."},{"issue":"4","key":"1256_CR34","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/cpt.2202","volume":"109","author":"SG Wicha","year":"2021","unstructured":"Wicha, S. G. et al. From therapeutic drug monitoring to Model-Informed precision dosing for antibiotics. Clin. Pharmacol. Ther. 109 (4), 928\u2013941 (2021).","journal-title":"Clin. Pharmacol. Ther."},{"issue":"5","key":"1256_CR35","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/FTD.0000000000000432","volume":"39","author":"CJ Hodiamont","year":"2017","unstructured":"Hodiamont, C. J. et al. Therapeutic drug monitoring of gentamicin peak concentrations in critically ill patients. Ther. Drug Monit. 39 (5), 522\u2013530 (2017).","journal-title":"Ther. Drug Monit."},{"issue":"2","key":"1256_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1208\/s12248-011-9255-z","volume":"13","author":"M Bergstrand","year":"2011","unstructured":"Bergstrand, M. et al. Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models. Aaps J. 13 (2), 143\u2013151 (2011).","journal-title":"Aaps J."},{"key":"1256_CR37","unstructured":"Du Bois, D. & Du Bois, E. F. A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition, 5(5): p. (1989). 303\u2009\u2013\u200911; discussion 312-3."},{"issue":"3","key":"1256_CR38","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3109\/00365513.2011.557086","volume":"71","author":"J Bj\u00f6rk","year":"2011","unstructured":"Bj\u00f6rk, J. et al. Revised equations for estimating glomerular filtration rate based on the Lund-Malm\u00f6 study cohort. Scand. J. Clin. Lab. Invest. 71 (3), 232\u2013239 (2011).","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"7","key":"1256_CR39","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1373\/clinchem.2013.220707","volume":"60","author":"A Grubb","year":"2014","unstructured":"Grubb, A. et al. Generation of a new Cystatin C-based estimating equation for glomerular filtration rate by use of 7 assays standardized to the international calibrator. Clin. Chem. 60 (7), 974\u2013986 (2014).","journal-title":"Clin. Chem."},{"key":"1256_CR40","unstructured":"Beal, S. L., Boeckmann, S. L. & Bauer, R. J. (eds) AJ, and, NONMEM 7.4 Users Guides. ICON plc. Gaithersburg, MD. (2017)."},{"issue":"6","key":"1256_CR41","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1038\/psp.2013.24","volume":"2","author":"RJ Keizer","year":"2013","unstructured":"Keizer, R. J., Karlsson, M. O. & Hooker, A. Modeling and simulation workbench for NONMEM: tutorial on Pirana, PsN, and xpose. CPT Pharmacometrics Syst. Pharmacol. 2 (6), e50 (2013).","journal-title":"CPT Pharmacometrics Syst. Pharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01256-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01256-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01256-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T18:28:44Z","timestamp":1747592924000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01256-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,18]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1256"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-01256-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,18]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"17262"}}